All Articles

To ensure optimal treatment selection and outcomes, differentiating between COVID-19 infection and interstitial lung disease is critical.

Efficacy of osimertinib as adjuvant therapy was demonstrated in ADAURA, a randomized, double-blind, placebo-controlled trial.

Positive findings from this study support channeling additional resources into telemedicine care for lung cancer, and into future randomized controlled trials to verify effectiveness.

The COVID-19 pandemic has highlighted how critical it is to maintain resilience and flexibility of the healthcare system and healthcare providers.

Clinical data are highlighted, providing an understanding of the benefits of treatment with tyrosine kinase inhibitors.

Everyone at the Academy of Oncology Nurse & Patient Navigators (AONN+) is committed to COVID-19 safety precautions to keep our staff, colleagues, collaborators, and members healthy.

The authors present their findings from a study of a nonclinical patient navigation program as a means to improve communication and foster a culture of understanding for patients and families transitioning between multiple healthcare facilities in a pediatric oncology network.

The authors present findings from their study of the use of the Teach Back method as an effective method in reinforcing or confirming patient education.

The COVID-19 pandemic changed everything, but for many patients with cancer, the fear of contracting the virus, as well as the toll of social isolation, were even more heightened than in the general public. According to Michele M. Hubert-Fiscus, MSN, RN, CCM, who spoke on COVID-19 and cancer at the AONN+ 11th Annual Navigation & Survivorship Conference, patients with cancer need their navigators to advocate for them, perhaps now more than ever.

Does “virtual medicine” represent the future of oncology navigation?